Atlas Trials

Study Evaluating the Safety of Myeliviz Myelin-Targeting PET Agent

Clinical trial NCT04333290 · WITHDRAWN

Trial details

NCT number
NCT04333290
Sponsor
Robert Fox
Status
WITHDRAWN
Phase
Early Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2024-07-24
Primary completion
2024-07-25
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.